Celularity Other Current Liab from 2010 to 2024

CELUW Stock  USD 0.02  0.0004  1.79%   
Celularity Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities will likely drop to about 2.3 M in 2024. During the period from 2010 to 2024, Celularity Other Current Liabilities regression line of quarterly data had r-squared of  0.25 and coefficient of variation of  200.79. View All Fundamentals
 
Other Current Liabilities  
First Reported
2019-03-31
Previous Quarter
11.1 M
Current Value
46.1 M
Quarterly Volatility
13.4 M
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.6 M, Interest Expense of 2.5 M or Selling General Administrative of 48.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Celularity over the last few years. It is Celularity's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Celularity Other Current Liab Regression Statistics

Arithmetic Mean3,266,554
Coefficient Of Variation200.79
Mean Deviation4,870,928
Median150,555
Standard Deviation6,558,970
Sample Variance43T
Range21.7M
R-Value0.50
Mean Square Error35T
R-Squared0.25
Significance0.06
Slope726,565
Total Sum of Squares602.3T

Celularity Other Current Liab History

20242.3 M
20232.4 M
202216.4 M
202111.7 M
202018.3 M
2019-3.5 M

About Celularity Financial Statements

Celularity investors use historical fundamental indicators, such as Celularity's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Celularity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities2.4 M2.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.